Last updated: January 6, 2026
Sponsor: King Chulalongkorn Memorial Hospital
Overall Status: Active - Not Recruiting
Phase
3
Condition
Low Blood Sodium (Hyponatremia)
Treatment
Ringer's Lactate Crystalloid Solutions
Normal saline
Clinical Study ID
NCT06030609
CUKT-FLUID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
A kidney transplant recipient who receives transplant at King Chulalongkorn MemorialHospital.
Age >=18 years
Both deceased donor and living donor kidney transplantation will be included
Exclusion
Exclusion Criteria:
multiorgan transplantation
Known allergy to RLS or NSS
Study Design
Total Participants: 159
Treatment Group(s): 2
Primary Treatment: Ringer's Lactate Crystalloid Solutions
Phase: 3
Study Start date:
September 01, 2024
Estimated Completion Date:
March 24, 2026
Connect with a study center
Division of Nephrology, Faculty of Medicine, King Chulalongkorn Memorial Hospital
Bangkok 1609350, Bangkok 1609348 10330
ThailandSite Not Available
Division of Nephrology, Faculty of Medicine, King Chulalongkorn Memorial Hospital
Bangkok, 10330
ThailandSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.